Recent PTAB victories include:
- Achieved victory for IPR petitioner on patent to a method of using an anti-cancer biologic. The decision helps clear our client's path to launching a biosimilar.
- Achieved victory for patent owner in IPRs involving patents on a novel drug dosing regimen. The decisions help protect our client's innovative drug.
- Achieved victory for IPR petitioner on patents to methods of using a nitrogen-scavenging drug. The decisions help clear our client's path to launching a generic drug.
Significant Hatch-Waxman and other litigation victories include:
- Win following ANDA bench trial relating to an extended release ADHD suspension. The decision helps clear our client's path to launching its generic drug.
- Represented a pharmaceutical company against a multi-billion dollar damages claim in a jury trial concerning an epilepsy drug. Case settled during trial, resulting in a favorable settlement.
- Win following ANDA bench trial relating to an extended release treatment for overactive bladder. The Federal Circuit affirmed.
- Represented a specialty supplements company concerning their krill oil products before the ITC, in a case that extended to the PTAB. A favorable settlement was reached.
- Obtained a $5.7M award at summary judgment for a nutritional supplements company in a trademark and copyright counterfeiting case.
- Represented a patent licensee in a patent infringement suit concerning mobile video technology used by spectators at sporting events.
- Represented a respondent in an ITC patent infringement trial concerning patents covering video analytics technology.
- Represented a pharmaceutical company in an action involving patents for an extended release formulation of an antibiotic. Helped overturn a preliminary injunction, allowing client to market its generic equivalent of the drug.
Ms. Hardman is an editor of the firm’s biosimilars-focused Big Molecule Watch blog, and a contributor to the firm’s Biosimilars Reference Guide and Guide to the Biosimilars Patent Dance.
She is a member of the Patent Trial and Appeal Board Bar Association.
Ms. Hardman’s recent pro bono work includes assisting students in obtaining special education services.
Prior to joining Goodwin in 2014, Ms. Hardman was a partner at Kenyon & Kenyon LLP in New York City, where her practice focused on patent litigation and counseling matters.